STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Texas on behalf of purchasers of Nobilis Health Corp. (NYSE MKT: HLTH) (“Nobilis” or the “Company”) securities during the period between April 2, 2015 and October 8, 2015, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until December 21, 2015 to seek appointment as lead plaintiff.
If you have suffered a loss from investment in Nobilis Health Corp. securities purchased on or after April 2, 2015 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at email@example.com or by telephone at (410) 415-6616. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company securities during the Class Period. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company’s claimed success rates for its AccuraScope procedure lacked recognition from any university, medical body, or insurance company, that the Company overstated its 2014 revenues by as much as $36 million and that the Company’s 2014 revenue growth rate was actually 44% as opposed to the 161% represented by the Company.
According to the complaint, following an October 9, 2015 Seeking Alpha article pointing out accounting red flags (four CFO changes in a handful of years; a recent auditor resignations; potentially overstated revenues; newly acquired acquisitions with Accounts Receivable issues) and questionable marketing (with paid studies touting inappropriate success rates for its medical procedures), the value of Nobilis shares declined significantly.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.